This plan specifies the type of GLP-1 medication (Semaglutide or Tirzepatide), starting dose, and any necessary adjustments over time
doi:10.1111/bph.15638 **" Cost of weight-loss drug Mounjaro could rise significantly (BBC) Acknowledgements : Id like to thank Sebastian Furness for his excellent article on the history of GLP-1 in The Conversation titled- The rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs This review was also extremely helpful: Zheng Z, Zong Y, Ma Y, et al
While branded semaglutide might strain budgets without insurance, Klinics insurance navigation and prior authorization support vastly mitigate costs for numerous patients
In turn, through facilitating substantial weight loss and via weight-independent pathways, GLP-1 receptor agonists improve glucose metabolism, cardiovascular health, kidney health, lipid disorders, liver health, and other outcomes